Effect of alfacalcidol on renal bone disease in mild to moderate renal failure. Questions remain over alfacalcidol's efficacy in preventing secondary hyperparathyroidism.
作者信息
Fournier A, Esper N E, Moriniere P, Oprisiu R, Marie A
出版信息
BMJ. 1995 Jul 8;311(6997):124; author reply 124-5. doi: 10.1136/bmj.311.6997.124b.
Abstract
摘要
相似文献
1
Effect of alfacalcidol on renal bone disease in mild to moderate renal failure. Questions remain over alfacalcidol's efficacy in preventing secondary hyperparathyroidism.阿法骨化醇对轻至中度肾衰竭患者肾性骨病的影响。关于阿法骨化醇预防继发性甲状旁腺功能亢进的疗效仍存在疑问。
BMJ. 1995 Jul 8;311(6997):124; author reply 124-5. doi: 10.1136/bmj.311.6997.124b.
2
Prevention of renal osteodystrophy in predialysis patients.
Am J Med Sci. 1999 Jun;317(6):398-404. doi: 10.1097/00000441-199906000-00008.
3
Effect of alfacalcidol on renal bone disease in mild to moderate renal failure. Monitoring the calcium-phosphate product is important.阿法骨化醇对轻至中度肾衰竭患者肾性骨病的影响。监测钙磷乘积很重要。
BMJ. 1995 Jul 8;311(6997):124; author reply 124-5. doi: 10.1136/bmj.311.6997.124a.
4
Hyperparathyroidism and the predictability of response to 1alpha-hydroxyvitamin D3.甲状旁腺功能亢进症与对1α-羟维生素D3反应的可预测性。
Clin Endocrinol (Oxf). 1977 Dec;7 Suppl:83s-84s. doi: 10.1111/j.1365-2265.1977.tb03366.x.
5
Calcium and phosphate metabolism in chronic renal failure, with particular reference to the effect of 1 alpha-hydroxyvitamin D3.
Acta Med Scand Suppl. 1980;638:3-120.
6
[Anomalies of phosphorus-calcium metabolism in renal insufficiency. Value of the physiopathological diagnosis and therapy].
Rev Rhum Mal Osteoartic. 1972 Oct;39(10):617-25.
7
The management of renal osteodystrophy.
Adv Exp Med Biol. 1977;81:533-47. doi: 10.1007/978-1-4613-4217-5_52.
8
[Progression of hyperparathyroidism during hemodialysis. Response to conservative treatment].[血液透析期间甲状旁腺功能亢进的进展。对保守治疗的反应]
Rev Clin Esp. 1982 Feb 15;164(3):163-7.
9
Vitamin D and analogues in renal bone disease and implications for osteoporosis.
Osteoporos Int. 1997;7 Suppl 3:S179-83. doi: 10.1007/BF03194368.
10
[Treatment with 1-alpha hydroxy vitamin D3 of bone disease in hemodialysis. Therapeutic results and complications].
Rev Clin Esp. 1980 Dec 15;159(5):317-22.
本文引用的文献
1
Effect of alfacalcidol on natural course of renal bone disease in mild to moderate renal failure.阿法骨化醇对轻至中度肾衰竭患者肾性骨病自然病程的影响。
BMJ. 1995 Feb 11;310(6976):358-63. doi: 10.1136/bmj.310.6976.358.
2
Preventing renal bone disease in moderate renal failure with CaCO3 and 25(OH) vitamin D3.使用碳酸钙和25（羟）维生素D3预防中度肾衰竭患者的肾性骨病。
Kidney Int Suppl. 1988 Mar;24:S178-9.
3
Soft tissue calcification in pediatric patients with end-stage renal disease.终末期肾病患儿的软组织钙化
Kidney Int. 1990 Nov;38(5):931-6. doi: 10.1038/ki.1990.293.
4
Ketodiet, physiological calcium intake and native vitamin D improve renal osteodystrophy.生酮饮食、生理钙摄入量和天然维生素D可改善肾性骨营养不良。
Kidney Int. 1992 Nov;42(5):1217-25. doi: 10.1038/ki.1992.407.
Zotero 插件